Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Melanoma × Positron-Emission Tomography × Clear all

Phase

Phase 2 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Hepatocellular 2 Vasculitis 1 Triple Negative Breast Neoplasms 1 Toxemia 1 Primary Ovarian Insufficiency 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pituitary Neoplasms 1 Pancreatic Cystic Neoplasms 1 Osteomyelitis 1 Neoplasm Metastasis 1 Muscle Weakness 1 Melanoma 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphatic Metastasis 1 Liver Neoplasms 1 Hematopoietic and Lymphoid System Neoplasm 1 Heart Diseases 1 Glioblastoma 1 Fever of Unknown Origin 1 Esophagogastric Cancer 1 Esophageal Neoplasms 1 Diabetes, Gestational 1 Dementia 1

Interventions

Blood Specimen Collection 12 Radiosurgery 7 Early Intervention, Educational 5 Surveys and Questionnaires 4 Standard of Care 4 Practice Guidelines as Topic 4 Methods 4 Educational Status 4 Surgical Procedures, Operative 3 Sentinel Lymph Node Biopsy 3 Nivolumab 3 Ipilimumab 3 Indocyanine Green 3 Immunotherapy 3 Cognitive Behavioral Therapy 3 Biopsy 3 pembrolizumab 2 montanide ISA 51 2 aldesleukin 2 X-Rays 2 Tomography, X-Ray Computed 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 In Situ Hybridization, Fluorescence 2 Immunohistochemistry 2 Immune Checkpoint Inhibitors 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Fluorescein 2 Diathermy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02236546 2017-04-13

FDG-PET in Advanced Melanoma

Vanderbilt-Ingram Cancer Center

Phase NA Terminated

3 enrolled 4 charts

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡